Public trial registry of the CCC-Munich

Trial CAIN457FDE03 ASTRUM

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
CAIN457FDE03 ASTRUM
World
Full title
:

A randomized, double-blind, placebo-corntrolled multicenter study of Secukinumab (AIN457) to examine the clinical efficacy and the NSAID-sparing effect of Secukinumab over 16 weeks in patients with ankylosing Spondylitis (ASTRUM)

World
Responsible organization
:
Nephrologie Tum
Indications
Classification Code Description
- M45.0 Spondylitis ankylosans
Trial design
World
Phase
:
IV
Status
World
Status
:
Recruitment active
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - vote date
:
2016-02-16
Initiiation & lock
World
Date of lock (planned / actual)
:
Unknown / Unknown
Therapy
World
Therapy
:

Komplementär - Therapieart: andere

Participants
Function Prename Surname Organization
World Responsible contact Klaus Thürmel Nephrologie Magnifier